Cite
HARVARD Citation
Möbus, V. et al. (2017). German Adjuvant Intergroup Node-positive Study (GAIN): a phase III trial comparing two dose-dense regimens (iddEPC versus ddEC-PwX) in high-risk early breast cancer patients. Annals of oncology. pp. 1803-1810. [Online].